Revive Therapeutics Ltd
Change company Symbol lookup
Select an option...
RVVTF Revive Therapeutics Ltd
DRTT DIRTT Environmental Solutions Ltd
BGSF BGSF Inc
NEE Nextera Energy Inc
PSB-Y PS Business Parks Inc
ADBE Adobe Inc
APWL Advanced Powerline Technologies Inc
J Jacobs Engineering Group Inc
HOV Hovnanian Enterprises Inc
ELCR Electric Car Company Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for infectious diseases and rare disorders. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.

Closing Price
$0.41
Day's Change
-0.0181 (-4.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.4407
Day's Low
0.39
Volume
(Above Average)
Volume:
674,721

10-day average volume:
597,963
674,721
  • Prev Close
    0.4281
  • Today's Open
    0.4369
  • Day's Range
    0.39-0.4407
  • Avg Vol (10-day)
    598.0K
  • Last (time)
    3:59p ET 12/02/21
  • Last (size)
    5.0K
  • 52-Wk Range
    0.195 - 0.72
    LowHigh
  • (12/02/20 - 12/14/20)
    110.26%
  • 99.7%
  • Market Cap
    130.4M
  • Shares Outstanding
    318.0M
  • -0.07
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.1
  • 2.59
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.